Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Urology|April 23, 2019
Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectivesLars Boesen
Danish Medical Journal|February 4, 2017
Multiparametric MRI in detection and staging of prostate cancerLars Boesen
Ugeskrift for Laeger|June 5, 2013
[Magnetic resonance imaging in management of prostate cancer]Lars Boesen, Henrik S Thomsen
Ugeskrift for Laeger|June 5, 2013
[Magnetic resonance imaging facilitate appropriate treatment selection of prostate cancer patients]Lars Boesen, Henrik S Thomsen
BJU International|November 12, 2024
Clinical value of contralateral biopsies in men with unilateral MRI foci undergoing targeted biopsyLars Boesen, Nis Nørgaard, Rasmus Bisbjerg, et al.
The Journal of Urology|February 26, 2017
Clinical Outcome Following Low Suspicion Multiparametric Prostate Magnetic Resonance Imaging or Benign Magnetic Resonance Imaging Guided Biopsy to Detect Prostate CancerLars Boesen, Nis Nørgaard, Vibeke Løgager, et al.
Scandinavian Journal of Urology|March 22, 2021
For men enrolled in active surveillance, pre-biopsy biparametric magnetic resonance imaging significantly reduces the risk of reclassification and disease progression after 1 yearKaren-Cecilie Kortenbach, Lars Boesen, Vibeke Løgager, et al.
Abdominal Radiology (New York)|November 1, 2022
Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsiesKaren-Cecilie Kortenbach, Vibeke Løgager, Henrik S Thomsen, et al.
Heliyon|November 25, 2021
Outcome of 5-year follow-up in men with negative findings on initial biparametric MRIKaren-Cecilie Kortenbach, Lars Boesen, Vibeke Løgager, et al.
Acta Radiologica Open|April 25, 2022
Early experience in avoiding biopsies for biopsy-naïve men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL<sup>2</sup>: A 2-year follow-up studyKaren-Cecilie Kortenbach, Vibeke Løgager, Henrik S Thomsen, et al.
Pageof 4